View in English?
View in English?
View in English?
| Cat. # | Size | Qty. | Price | Inventory |
|---|---|---|---|---|
| 42521T | 1 Kit (9 x 20 microliters) |
|
| Product Includes | Quantity | Applications | Reactivity | MW(kDa) | Isotype |
|---|---|---|---|---|---|
| LRP1 (E2Q7S) Rabbit mAb 26387 | 20 µl |
|
H M R | 85 | Rabbit IgG |
| ApoE (pan) (D7I9N) Rabbit mAb 13366 | 20 µl |
|
H | 35 | Rabbit IgG |
| Tau (D1M9X) XP® Rabbit mAb 46687 | 20 µl |
|
H M R | 50-80 | Rabbit IgG |
| Phospho-Tau (Thr181) (D9F4G) Rabbit mAb 12885 | 20 µl |
|
H M R | 50-80 | Rabbit IgG |
| Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb 20194 | 20 µl |
|
H M R | 50-80 | Rabbit IgG |
| SORL1 (D8D4G) Rabbit mAb 79322 | 20 µl |
|
H M | 250 | Rabbit IgG |
| Rab5 (C8B1) Rabbit mAb 3547 | 20 µl |
|
H M R Mk | 25 | Rabbit |
| Rab7 (D95F2) XP® Rabbit mAb 9367 | 20 µl |
|
H M R Mk | 23 | Rabbit IgG |
| Rab11 (D4F5) XP® Rabbit mAb 5589 | 20 µl |
|
H M R Mk | 25 | Rabbit IgG |
| Anti-rabbit IgG, HRP-linked Antibody 7074 | 100 µl |
|
Rab | Goat |
Product Information
Monoclonal antibodies are produced by immunizing animals with synthetic peptides corresponding to residues surrounding Leu4488 of human LRP1 protein, Pro285 of human ApoE protein, Asp430 of human tau protein, Glu267 of human SORL1 protein, Gly190 of human Rab5A protein, and Glu188 of human Rab7 protein, respectively. Rab11 (D4F5) XP® Rabbit mAb is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human Rab11 protein. Phospho-Tau (Thr181) (D9F4G) Rabbit mAb and Phospho-Tau (Ser404) (D2Z4G) Rabbit mAb (IF preferred) are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr181 of human Tau protein and Ser400/Thr403/Ser404 of human Tau protein, respectively.
Tau is a heterogeneous microtubule-associated protein that promotes and stabilizes microtubule assembly, especially in axons. In addition to its normal function, intracellular neurofibrillary tangle protein aggregates, composed of hyperphosphorylated helical bundles of tau, are a major hallmark of neurodegenerative diseases like Alzheimer's disease (AD) (1). Moreover, disease progression is also measured by the progressive spread and deposition of the protein aggregates via intercellular transfer of tau (2). Although the intercellular mechanism of protein aggregate transfer is poorly understood, low density lipoprotein receptor related protein 1 (LRP1) was identified as a regulator of tau uptake and spread (3). LRP1 is a type I transmembrane receptor that mediates the endocytosis of various ligands, including apolipoproteins and tau. Interestingly, human apolipoprotein E (ApoE), which also binds to LRP1, is genetically linked to AD (4). LRP1-mediated protein uptake, in addition to tau, may play an important role in AD progression. In addition to LRP1, other low density lipoprotein receptor related proteins, including SORL1, are genetically linked to AD, suggesting a conserved cellular mechanism that converges on this family of proteins that contributes to AD etiology (5). Once tau binds to LRP1, receiving cells are likely to internalize and process tau via the endosomal pathway, completing cell-to-cell transmission. Rab5, Rab7, and Rab11, members of the Ras superfamily of small Rab GTPases, are likely to regulate endosomal processing of tau (6).
Explore pathways related to this product.
STRING - Known and Predicted Protein-Protein Interactions.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.
View in English?
PhosphoSitePlus®